Furosemide

Furosemide

SCHEMBL3095277

NS(=O)(=O)c1cc(C(=O)[O-])c(NCc2ccco2)cc1Cl.NS(=O)(=O)c1cc(C(=O)[O-])c(NCc2ccco2)cc1Cl.[Mg+2]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC12A1

The experimentally established mechanism targets of Furosemide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 6/20 0.80
CA1 P00915 6/20 0.80
CA2 P00918 6/20 0.80
CA9 Q16790 6/20 0.80
CA6 P23280 5/20 0.80
CA7 P43166 5/20 0.80
CA14 Q9ULX7 5/20 0.80
CA5B Q9Y2D0 5/20 0.80
CISD1 Q9NZ45 4/20 0.80
CA5A P35218 4/20 0.80
ALDH1A1 P00352 2/20 0.80
HTR1A P08908 1/20 0.80
CA4 P22748 1/20 0.80
HSD11B1 P28845 1/20 0.80
SLC10A1 Q14973 1/20 0.80
GPR35 Q9HC97 1/20 0.80
ABCG2 Q9UNQ0 1/20 0.80
APP P05067 9/20 0.64
AQP1 P29972 1/20 0.55
TEX264 Q9Y6I9 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Furosemide SCHEMBL6751173 0.98 CA12 (0.80) CA12CA1CA2CA9CA6
Furosemide SCHEMBL11793416 0.98 CA12 (0.80) CA12CA1CA2CA9CA6
Furosemide SCHEMBL2947473 0.98 CA12 (0.80) CA12CA1CA2CA9CA6
Furosemide SCHEMBL18729742 0.98 CA12 (0.80) CA12CA1CA2CA9CA6
Furosemide SCHEMBL30369125 0.98 CA12 (0.80) CA12CA1CA2CA9CA6
SCHEMBL229073 0.90 CA12 (0.85) CA12CA1CA2CA9CA6
Furosemide SCHEMBL29406913 0.89 CISD1 (1.00) CA12CA1CA2CA9CA6
SCHEMBL2880956 0.89 CA12 (0.83) CA12CA1CA2CA9CA6
Furosemide SCHEMBL428921 0.89 CISD1 (1.00) CA12CA1CA2CA9CA6
Furosemide SCHEMBL9811 0.89 CISD1 (1.00) CA12CA1CA2CA9CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799937-B2 Metal coordinated compositions SYNTHONICS, INC. (US) 2010-09-21 US disclosed
US-20080015352-A1 Metal coordinated compositions HTERT3, INC. 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015352-A1 Metal coordinated compositions SLC30A6, SLC39A7, SLC39A14 CA12 125/4885CA1 192/4885CA2 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.